Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes by Tupper, J et al.
SHORT COMMUNICATION
Breast tumor kinase (Brk/PTK6) plays a role in the differentiation
of primary keratinocytes
J. Tupper • M. R. Crompton • A. J. Harvey
Received: 7 October 2010 / Revised: 16 December 2010 / Accepted: 29 December 2010
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Breast Tumor Kinase (Brk/PTK6) has a rela-
tively limited expression profile in normal tissue. Its
expression is restricted to epithelial cells that are differ-
entiating such as those in the epidermis, and Brk expression
appears to be absent from proliferating cells in normal
tissue. Also, there is now some evidence to suggest that
Brk plays a functional role in the differentiation of the
keratinocytes in the epidermis. We have, therefore, inves-
tigated the role that Brk/PTK6 plays in normal human
primary keratinocytes by suppressing protein levels using
RNA interference. We show that as primary human
keratinocytes are induced to differentiate in vitro, Brk
levels decrease. Decreasing Brk protein levels lead to an
increase in the number of cells with a permeable plasma
membrane, a decrease in epidermal growth factor receptor
(EGFR) and a parallel increase in keratin 10 levels, but
classical markers of apoptosis or terminal differentiation
are not affected. We propose Brk, Keratin 10 and EGFR
are co-regulated during differentiation and that manipu-
lating Brk expression can influence the differentiation of
normal primary human keratinocytes.
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Introduction
Keratinocyte differentiation is tightly controlled and
involves a range of signals and events, including tyrosine
kinase activation, that are important in regulation. Signal-
ing downstream of the epidermal growth factor receptor
(EGFR) in the presence of constitutively active AKT ini-
tiates the growth arrest and differentiation process in
response to elevated calcium [1], while decreased EGFR
levels and signaling are associated with terminal differen-
tiation [14].
The breast tumor kinase (Brk/PTK6) is a known
potentiator of EGF signaling [8, 9] and an inhibitor of Akt
[5, 25] and, its suppression decreases proliferation of breast
cancer cells [6]. Although originally identified in breast
carcinomas [13], Brk’s expression profile in normal tissue
is relatively restricted. Brk and its mouse orthologue, Sik,
are found in differentiating epithelia. Brk expression has
been identified in epithelial cells of the GI tract [12], epi-
dermis [19, 21], prostate [3], and oral mucosa [15].
In addition to the expression profile in differentiating
epithelia, there is an evidence to suggest that Brk plays a
functional role in keratinocyte differentiation. Brk over-
expression in the keratinocyte cell line HaCaT results in
moderately elevated expression of a known keratinocyte
differentiation marker, keratin 10 [21]. Increased Brk-
associated kinase activity was observed in HaCaT cells,
induced to differentiate with calcium [21]. Similar results
were seen in primary murine keratinocytes where activity
of Sik increased rapidly following the calcium treatment
[20].
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We investigated the role that Brk plays in normal human
primary keratinocytes by suppressing protein levels using
RNA interference. We hypothesized that since differenti-
ating agents can increase Brk activity, the suppression of
Brk expression would alter primary keratinocyte differen-
tiation in vitro.
Materials and methods
Cell culture
Normal human adult keratinocytes were purchased from
TCS Cell Works, maintained in Epilife media supple-
mented with full supplement and antibiotics (Cascade Bi-
ologics Inc., USA) and used below passage ten.
For calcium differentiation studies, cells were plated at
37,500 cm-2. 24 h later medium was changed for medium
plus 1.2 mM Ca2? for 5 days, at which point cells dis-
played an altered morphology and decreased growth
compared with controls.
Methylcellulose (MC) studies were performed according
to Watt [23]. Briefly, 2 9 105 cells were suspended for
48 h in 2 ml methylcellulose per well of a polyHEMA-
coated 6-well plate (Sigma).
RNA interference
Cells were transfected with Brk-targeting (50-GGUGAUU
UCUCGAGACAACTT-30) or Control siRNA (50-GGA
CACCAUCAAGUGUUCGTT-30) (Dharmacon). Two
transfections were performed 24 h apart on 105 cells with
the siRNA duplex (120 nM) and Oligofectamine (Invitro-
gen) in OptiMEM medium using the manufacturer’s
guidelines.
Trypan blue staining
Cell viability was determined using trypan blue exclusion.
Cells were mixed with the stain to a final trypan blue
concentration of 0.1% and counted using an improved
neubauer hemocytometer. Cells that appeared blue when
visualized by light microscopy were classed as nonviable.
Cell death ELISA
Cell death levels were measured using a cell death detec-
tion ELISA (Roche).
Western blotting
Cells were lysed in 29 SDS-PAGE loading buffer and sep-
arated by SDS-PAGE. Equal loading was determined by
coomassie-blue staining and the presence of housekeeping
proteins. Separated proteins were transferred to nitrocellulose
membranes by electro-blotting in Towbin buffer. Membranes
were incubated with antibodies to GAPDH, b-actin (Abcam),
EGFR, K10, involucrin (Sigma) and Brk (ICR-100) [9] and
proteins visualized with an appropriate HRP-conjugated
secondary antibody and chemiluminescence.
Results and discussion
Keratinocytes are one of the few sites of physiological Brk
expression [20, 21], however, Brk’s role in these cells has
yet to be fully characterized. In this study normal human
keratinocytes were used as model for studying the role of
Brk in human primary cells.
Primary non-immortalized keratinocytes were induced
to differentiate by either increasing the calcium concen-
tration of the medium or by resuspending the cells in
methylcellulose. When cells were suspended in methyl-
cellulose for 48 h or cultured in calcium for up to 5 days
the levels of both Keratin 10 and involucrin increased. Brk
protein levels decreased under these conditions suggesting
that, as cells become more terminally differentiated Brk
protein decreases (Fig. 1a).
To determine whether experimentally decreasing Brk
expression resulted in differentiation, RNA interference
was used to decrease Brk protein expression. Brk sup-
pression (Fig. 1b) resulted in an increase in the percentage
of cells incorporating trypan blue both 24 and 48 h fol-
lowing the second transfection compared with control
transfectants (Fig. 1c). This increase was seen with two
different Brk-targeting siRNA sequences (data not shown).
Membrane permeabilization to trypan blue could be
regarded as a sign of cell death, however, it is also an early
sign of keratinocyte differentiation. Western blot analysis
revealed that on Brk suppression, Keratin 10 levels
increased (Fig. 1b), although there were no observable
changes in levels of the differentiation markers Keratin 1
and involucrin, or activation markers Keratin 6 and 16
(data not shown).
The effects of Brk-suppression on cell membrane
integrity coupled with an increase in Keratin 10 suggest
that Brk suppression may contribute to primary keratino-
cyte differentiation. However, as levels of other differen-
tiation markers were unaffected, it is likely that
downregulation of Brk may be an early/intermediate event
in differentiation and is not a sufficient signal alone to fully
mediate the differentiation process. Activation status could
be important, although Brk expression is differential in
epidermal layers [20, 21].
The level of cytosolic, histone-bound DNA was deter-
mined by DNA ELISA as a measure of chromatin
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fragmentation, and a significant increase in DNA frag-
mentation in cells with suppressed Brk, compared with
controls, was observed (Fig. 2a).
Keratinocyte terminal differentiation is associated with
some cell death features such as DNA fragmentation
although these findings are inconsistent [17, 24].
Therefore to determine whether the observed increase in
cell permeability and chromatin fragmentation, in Brk-
suppressed cells, might be a result of differentiation,
keratinocytes were induced to differentiate by increasing
culture calcium concentrations or by suspension culture in
methylcellulose. The well-documented method of differ-
entiating keratinocytes in methylcellulose [18] resulted in
DNA fragmentation (Fig. 2a). However, differentiation
with increased calcium did not result in any observable
increase in chromatin fragmentation using the cell death
ELISA (unpublished observation) suggesting that DNA
fragmentation can accompany keratinocyte differentiation,
but this phenomenon is observed only in certain types of
differentiation which may account for previously incon-
sistent findings. It is also striking that the level of chro-
matin fragmentation observed when cells were cultured on
methylcellulose is much greater than that observed on Brk
suppression. It is probable that methylcellulose culture
affects a number of cellular pathways and processes
involved in differentiation and that Brk contributes to this.
However, it is unlikely that Brk is the only contributor to
differentiation, which would account for the lesser effects
in Brk-suppressed cells.
We have previously reported that Brk expression pro-
tected breast cancer cells from suspension-induced cell
death [7]. Given that in vivo, Brk expression is increased in
differentiating cells that are in transit away from the epi-
dermal basement membrane, and that untransformed cells
are dependent on contact with basement membrane/sub-
stratum for survival [4], we hypothesize that a function of
Brk in early differentiating cells may be to promote their
survival. The subsequent decrease in Brk levels that
occurred when keratinocytes continued to differentiate
might occur as a requirement of the differentiation process
in primary cells. The expression of cell surface receptors
associated with Brk signaling, such as EGFR, has been
shown to decrease in vivo as cells commit to terminal
differentiation [11, 14]. Inhibition of EGFR signaling
Fig. 1 Brk levels are reduced in differentiation. a Normal human
primary keratinocytes were induced to differentiate by either cultur-
ing in methylcellulose for 48 h (MC) (left hand panel) or in medium
containing 1.2 mM Calcium ions for 5 days (Calcium) (right hand
panel). Control cells were cultured under normal adherent culture
conditions (Control). Cells were lysed in hot SDS-PAGE lysis buffer
and relative protein levels determined by western blotting. Brk levels
were then suppressed in normal human primary keratinocytes by
RNAi. b 48 h following the second transfection with control
(Control) or Brk-targeting siRNA (Brk siRNA), cells were lysed in
hot SDS-PAGE lysis buffer and relative protein levels determined by
western blotting. c 24 and 48 h following the second transfection with
control (filled bars) or Brk-targeting siRNA (open bars) cells were
harvested, resuspended in 0.1% trypan blue and the percentage of
nonviable cells determined
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induces growth arrest and keratinocyte differentiation
[16]. As Brk enhances the effects of signaling via Erb
receptors [8, 9] suppression of Brk would be predicted to
reduce the effects of Erb signaling, in which this cellular
context results in a more differentiated phenotype. Con-
versely EGF treatment of a serum-free epidermal culture
model resulted in decreased differentiation [2] and an
elevated expression of EGFR in differentiating cells, and
presumably therefore activation of EGFR signaling,
resulted in hyperproliferation [22]. Downregulation of
EGFR signaling appears to be a requirement of kerati-
nocyte differentiation and the reduction in signaling could
be enhanced by reduced Brk levels. We propose that this
may be a supplementary mechanism that contributes to
the subsequent differentiation. In addition, we found that
EGFR protein levels were decreased on Brk suppression
in primary keratinocytes (Fig. 2b), which supports recent
findings that Brk inhibits EGFR downregulation [10]. Brk
suppression in keratinocytes may, therefore, be a mech-
anistic prerequisite for reduced EGFR levels in
differentiation.
Conclusions
This is the first study in normal primary human cells
demonstrating co-regulation of Brk and keratin 10 in dif-
ferentiation. The data presented link Brk mechanistically to
keratinocyte differentiation (via Keratin 10 and EGFR
expression) and demonstrate that manipulating Brk affec-
ted phenotypic outcome. The results of this and other
studies [20, 21] suggest that Brk plays an important,
complex role in normal human keratinocyte differentiation
and that this role could be keratinocyte-specific.
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